This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (98)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Initial Clinical Results in 18 Patients

George S. Allen, MD, PhD; R. Stanley Burns, MD; Noel B. Tulipan, MD; Robert A. Parker, DSc

Arch Neurol. 1989;46(5):487-491.

Abstract
• Results from a pilot study of adrenal medullary autotransplantation for Parkinson's disease are presented. Eighteen patients were studied; 12 were followed up for 1 year, and 6 were followed up for 6 months. Four of 12 patients showed distinct improvement in the signs and symptoms of their disease, as assessed using the Columbia Rating Scale, at 1 year; none showed distinct deterioration. The 6 patients who were followed up for only 6 months were an average of 20 years older and generally more severely affected. None distinctly improved. Morbidity was considered to be minor and transient among the first 12 patients, while 4 of the last 6 patients experienced alteration in mental status lasting as long as several months. This problem has led us to conclude that older patients with preexisting cognitive impairment should not be included in future studies until the benefits are more clearly established. However, we believe that the distinct and persistent improvement seen in some of the younger patients warrants the initiation of a welldesigned, randomized, and controlled trial of adrenal medullary autotransplantation for the purpose of confirming these results and assessing the effect of the procedure on the natural progression of Parkinson's disease.

Author Affiliations
From the Departments of Neurological Surgery (Drs Allen and Tulipan), Neurology and Psychiatry (Dr Burns), and Preventive Medicine (Dr Parker), Vanderbilt University Medical Center, Nashville, Tenn.

Footnotes
Accepted for publication December 1, 1988.

Reprint requests to Department of Neurosurgery, T4224 MCN, Vanderbilt University Hospital, Nashville, TN 37232-2380 (Dr Allen).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Long-term Follow-up of Adrenal Medullary Transplantation for Parkinson's Disease
Waters et al.
J Geriatr Psychiatry Neurol 1992;5:35-39.
ABSTRACT  

Stereotaxic Implantation of Autologous Adrenal Medulla Into Caudate Nucleus in Four Patients With Parkinsonism: One-Year Follow-up
Fazzini et al.
Arch Neurol 1991;48:813-820.
ABSTRACT  

Intraputaminal Infusion of Nerve Growth Factor to Support Adrenal Medullary Autografts in Parkinson's Disease: One-Year Follow-up of First Clinical Trial
Olson et al.
Arch Neurol 1991;48:373-381.
ABSTRACT  

Fetal Homotransplants (Ventral Mesencephalon and Adrenal Tissue) to the Striatum of Parkinsonian Subjects
Madrazo et al.
Arch Neurol 1990;47:1281-1285.
ABSTRACT  

Autologous Transplantation of Adrenal Medulla in Parkinson's Disease: 18-Month Results
Olanow et al.
Arch Neurol 1990;47:1286-1289.
ABSTRACT  

Transplantation of Human Fetal Dopamine Cells for Parkinson's Disease: Results at 1 Year
Freed et al.
Arch Neurol 1990;47:505-512.
ABSTRACT